Navigation Links
A new Vaccine for Pneumonia

Researchers show a new type of vaccine can reduce the incidence of pneumonia in children with and without human immunodeficiency virus (HIV). //

Acute respiratory infections are a major cause of death in children under age 5. Additionally, pneumonia is becoming increasingly resistant to antibiotics. Doctors from around the world are in search of new methods to treat the illness. Researchers, conducted a study with nearly 40,000 children in South Africa. At 6 weeks, 10 weeks and 14 weeks of age, half of the children received the 9-valent pneumococcal polysaccharide vaccine. All of the children received the flu vaccine.

The researchers found the pneumonia vaccine decreased the rate of the particular strain of pneumonia in the vaccine, by 72 percent. It also reduced the rate of confirmed cases by 17 percent. In an accompanying editorial, the authors write, “The decrease in these two outcomes were remarkably similar in both U.S. children and South African children. However, in South Africa about one third of the cases of invasive disease caused by serotypes included in the vaccine were associated with meningitis, a much higher proportion than in the United States.”

This vaccine, according to the study investigators, may be useful in countries where HIV infection is a significant cause of pneumonia. It also may reduce the risk of antibiotic resistance. However researchers noted an increase in asthma in those who received the vaccine, but that reason is not yet understood.


'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. Vaccine Reduces antibiotic-resistant infections in Children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... , ... June 28, 2017 , ... ... management and financial planning assistance to clients in southern Montana, is announcing a ... by Zoo Montana. , The outreach programs offered by Zoo Montana provide students ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... DrugDev ... study is whether they can trust the sponsor to pay them correctly and on ... sponsors and CROs establish payment strategies that encourage sites to work on their studies. ...
(Date:6/27/2017)... ... 2017 , ... The Congressional Budget Office (CBO) projects that the Better Care ... Protection and Affordable Care Act (ACA), would result in 22 million Americans losing their ... , More than 20 million Americans have gained health insurance under the ACA, and ...
(Date:6/27/2017)... ... , ... A January 18th article on medGadget reports that the ... the year 2024 according to a new report. The article also notes that the ... Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center says that it ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... HORSHAM, Pa. , June 19, 2017  Researchers ... announced today that they will host a live, complimentary ... Perspectives from the benchtop to the real world" on ... PM EDT. This webinar will feature ... a rare look into the manipulation techniques abusers use ...
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: